Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Chen

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer Research|May 4, 2018
Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath TumorsJacqueline D Peacock, Matthew G Pridgeon, Elizabeth A Tovar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in <i>Pten</i>-deleted Mouse Models of SarcomaRebecca D Dodd, Amanda Scherer, Wesley Huang, et al.
Epidemiology and Infection|April 5, 2021
Identifying COVID-19 cases in outpatient settingsYinan Mao, Yi-Roe Tan, Tun Linn Thein, et al.
Research Square|March 2, 2022
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecovirusesLin-Fa Wang, Chee Wah Tan, Wan Ni Chia, et al.
Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Journal of Medicinal Chemistry|October 24, 2022
Overcoming Preclinical Safety Obstacles to Discover (<i>S</i>)-<i>N</i>-((1,2,3,5,6,7-Hexahydro-<i>s</i>-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5<i>H</i>-pyrazolo[5,1-<i>b</i>][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 InhibitorChristopher McBride, Lynnie Trzoss, Davide Povero, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Nature Medicine|May 8, 2024
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolutionLorenzo Subissi, James Richard Otieno, Nathalie Worp, et al.
Nature Medicine|May 31, 2022
An early warning system for emerging SARS-CoV-2 variantsLorenzo Subissi, Anne von Gottberg, Lipi Thukral, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Research|May 4, 2018
Genomic Status of <i>MET</i> Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath TumorsJacqueline D Peacock, Matthew G Pridgeon, Elizabeth A Tovar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in <i>Pten</i>-deleted Mouse Models of SarcomaRebecca D Dodd, Amanda Scherer, Wesley Huang, et al.
Epidemiology and Infection|April 5, 2021
Identifying COVID-19 cases in outpatient settingsYinan Mao, Yi-Roe Tan, Tun Linn Thein, et al.
Research Square|March 2, 2022
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecovirusesLin-Fa Wang, Chee Wah Tan, Wan Ni Chia, et al.
Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Journal of Medicinal Chemistry|October 24, 2022
Overcoming Preclinical Safety Obstacles to Discover (<i>S</i>)-<i>N</i>-((1,2,3,5,6,7-Hexahydro-<i>s</i>-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5<i>H</i>-pyrazolo[5,1-<i>b</i>][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 InhibitorChristopher McBride, Lynnie Trzoss, Davide Povero, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Nature Medicine|May 8, 2024
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolutionLorenzo Subissi, James Richard Otieno, Nathalie Worp, et al.
Nature Medicine|May 31, 2022
An early warning system for emerging SARS-CoV-2 variantsLorenzo Subissi, Anne von Gottberg, Lipi Thukral, et al.
Pageof 7